A comparison of the protective effect of methisazone and a hyperimmune antivaccinial gamma-globulin in primary smallpox vaccination carried out in the presence of contraindications.
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D012900:Smallpox Vaccine / Q000009:adverse effects*; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014611:Vaccination / Q000009:adverse effects; D005719:gamma-Globulins / Q000627:therapeutic use*
D000998:Antiviral Agents; D012900:Smallpox Vaccine; D013882:Thiosemicarbazones; D005719:gamma-Globulins